ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CODX Co Diagnostics Inc

1.11
-0.12 (-9.76%)
10 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Co Diagnostics Inc CODX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.12 -9.76% 1.11 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.17 1.03 1.19 1.11 1.23
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:01EDGAR2Form 8-K - Current report
09/5/202415:01PRNUSCo-Diagnostics, Inc. Reports First Quarter 2024 Financial..
25/4/202408:30PRNUSCo-Diagnostics, Inc. Announces First Quarter 2024 Earnings..
24/4/202408:30PRNUSCo-Diagnostics, Inc. to Host Booth and Deliver Presentation..
12/4/202408:30PRNUSCo-Diagnostics, Inc. Inaugurates New Manufacturing Facility..
04/4/202408:30PRNUSCo-Diagnostics, Inc. Appoints New President and Other..
21/3/202408:30PRNUSCo-Diagnostics, Inc. CEO Delivers Manufacturing and..
18/3/202408:30PRNUSCo-Diagnostics, Inc. CEO to Deliver Keynote Address at..
14/3/202415:01PRNUSCo-Diagnostics, Inc. Reports Full Year 2023 Financial..
07/3/202408:30PRNUSCo-Diagnostics, Inc. JV CoSara Receives Clearance from..
29/2/202408:30PRNUSCo-Diagnostics, Inc. Announces Fourth Quarter and Full Year..
01/2/202408:30PRNUSCo-Diagnostics, Inc. Shares List of Upcoming Industry..
03/1/202408:30PRNUSCo-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
27/12/202308:30PRNUSCo-Diagnostics, Inc. Completes Submission to FDA for Co-Dx..
29/11/202308:30PRNUSCo-Diagnostics, Inc. to Participate in the Piper Sandler..
27/11/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:01EDGAR2Form 8-K - Current report
09/11/202315:01PRNUSCo-Diagnostics, Inc. Reports Third Quarter 2023 Financial..
02/11/202308:30PRNUSCo-Diagnostics, Inc. Announces Additional Grant Award for..
31/10/202308:30PRNUSCo-Diagnostics, Inc. Shares List of Upcoming Industry..
26/10/202308:30PRNUSCo-Diagnostics, Inc. Announces Third Quarter 2023 Earnings..
23/10/202308:30PRNUSCo-Diagnostics, Inc. to Host Booth at CASMET Symposium..
16/10/202308:30PRNUSCo-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in..
27/9/202308:30PRNUSCo-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL..
22/9/202308:30PRNUSCo-Diagnostics, Inc. to Participate in 6th ACTC Conference..
21/9/202308:30PRNUSCo-Diagnostics, Inc. to Participate in Gilmartin Group..
07/9/202308:30PRNUSCo-Diagnostics, Inc. to Participate in the H.C. Wainwright..
31/8/202315:05EDGAR2Form 8-K - Current report
29/8/202308:30PRNUSCo-Diagnostics, Inc. Appoints Chief Regulatory Affairs..
18/8/202308:30PRNUSCo-Diagnostics, Inc. to Present at 15th Next Generation Dx..
16/8/202310:30PRNUSCo-Diagnostics, Inc. to Host Booth at Medlab Asia Conference..
10/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:03EDGAR2Form 8-K - Current report
10/8/202315:01PRNUSCo-Diagnostics, Inc. Reports Second Quarter 2023 Financial..
27/7/202308:30PRNUSCo-Diagnostics, Inc. Announces Second Quarter 2023 Earnings..
20/7/202308:30PRNUSCo-Diagnostics, Inc. to Host Booth and Discuss Recent Grant..
20/7/202305:10EDGAR2Form DEF 14A - Other definitive proxy statements
18/7/202308:30PRNUSCo-Diagnostics, Inc. Announces Recent Grant Awards
13/7/202308:30PRNUSCo-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home..